Iopamidol

Iopamidol

Clinical data
Pregnancy category	US: B (No risk in non-human studies)
Routes of administration	Intravascular
ATC code	V08AB04 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
IUPAC name N,N'-Bis(1,3-dihydroxypropan-2-yl)-5-[ [(2S)-2-hydroxypropanoyl]amino]-2,4,6 -triiodobenzene-1,3-dicarboxamide
PubChem CID	65492
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C17H22I3N3O8
Molar mass	777.08 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Iopamidol (INN, tradenames Iopamiro, Isovue, and Iopamiron) is a nonionic, low-osmolar iodinated contrast agent, developed by Bracco.

It is available in various concentrations, from 200 to 370 mgI/mL.

Clinical uses

Iopamidol is primarily used in the following:

• Angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, coronary arteriography and ventriculography, pediatric angiocardiography, selective visceral arteriography and aortography, peripheral venography (phlebography)
• Adult and pediatric intravenous excretory urography and intravenous adult and pediatric contrast enhancement of computed tomographic (CECT) head and body imaging

External links

• Isovue (iopamidol) Injection, Solution
• Iopamidol

Template:WH